Learn languages naturally with fresh, real content!

Popular Topics
Explore By Region
Nordic Capital and Permira propose to buy Bavarian Nordic for DKK 19 billion, a 21% premium.
A consortium led by Nordic Capital and Permira has proposed to buy Danish biopharmaceutical company Bavarian Nordic for about DKK 19 billion, offering DKK 233 per share, a 21% premium.
Bavarian Nordic's board and executives agree to tender their shares.
If successful, the deal would delist the company from Nasdaq Copenhagen.
The transaction, expected to close by end of 2025, is subject to regulatory approvals and other conditions.
5 Articles
Nordic Capital y Permira proponen comprar Bavarian Nordic por 19 000 millones de DKK, con una prima del 21%.